Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1667521

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to take steps to make (a) Cefiderocol and (b) Ceftazidimethose available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	220
answer	answer is ministerial correction date of answer 09/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NICE published guidance in August 2022 recommending both ceftazidime with avibactam and cefiderocol for treating severe drug-resistant gram-negative bacterial infections. This was as part of a project to test a new health technology evaluation process and payment model for antimicrobial products. NHS England has now issued contracts with the suppliers and cefiderocol and ceftazidime with avibactamare available for clinicians to prescribe in line with NICE’s recommendations.</p> answering member constituency Colchester answering member printed Will Quince question first answered 09/11/2023 17:51:11 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1604132

registered interest
date	14/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of hoarding in the global manufacturing supply chain of antibiotics on the prices of antibiotics in the UK.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	165203
answer	answer is ministerial correction date of answer 21/03/2023 answer text <p>No assessment has been made. Since 2019, the Government has restricted the export and hoarding of some medicines already placed on the United Kingdom market where there is evidence of a critical shortage, or a risk of a critical shortage, which could adversely impact UK patients.</p><p>For unbranded generic medicines the Department relies on competition to keep prices down. This has led to some of the lowest prices in Europe and allows prices to react to the market. In an international market this ensures that when demand is high and supply is low, prices in the UK can increase to help secure the availability of medicines for UK patients. Branded medicines spend is controlled through the Branded Health Service Medicines (Costs) Regulations 2018 and the 2019 voluntary scheme for branded medicines pricing and access.</p><p>In the UK, anti-competitive behaviour, including hoarding, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.</p> answering member constituency Colchester answering member printed Will Quince question first answered 21/03/2023 17:00:39 answering member 4423 label Biography information for Will Quince
tabling member	350 label Biography information for Sir John Hayes

1564437

registered interest
date	06/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce the cost of the charge to the NHS for antibiotics.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	117449
answer	answer is ministerial correction date of answer 13/01/2023 answer text <p>The Government relies on competition to drive down prices of generic medicines such as antibiotics. This has led to some of the lowest prices in Europe. Freedom of pricing enables supplies to put prices up quickly to ensure we maintain continuity of supply despite increasing prices within the global market. In secondary care, tendering for antibiotics on a frequent basis ensures best value and supply resilience is optimised.</p><p>No supplier should use the current situation as an opportunity to exploit the National Health Service. Where companies are found to be abusing their dominant position by charging excessive and unfair prices, the Competition and Markets Authority (CMA) can take action against businesses and individuals engaged in anti-competitive conduct. The CMA is working to establish the facts of what is currently happening in the antibiotic market. They stand ready to take action if there is evidence of anti-competitive behaviour that breaks the law.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/01/2023 13:26:35 answering member 4423 label Biography information for Will Quince
tabling member	318 label Biography information for John Spellar

1524723

registered interest
date	20/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the (a) dangers and (b) legality of sharing antibiotics; and if she will make a statement.
tabling member constituency	Warrington North
tabling member printed	Charlotte Nichols
uin	68018
answer	answer is ministerial correction date of answer 03/11/2022 answer text <p>All use of antimicrobials can drive resistance, so they should only be used when necessary. The Government supports various initiatives to strengthen the stewardship and support the appropriate use of antimicrobials. Sharing prescription medications, including antibiotics, is against the law.</p> answering member constituency Colchester answering member printed Will Quince question first answered 03/11/2022 13:12:54 answering member 4423 label Biography information for Will Quince
tabling member	4799 label Biography information for Charlotte Nichols